Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Xenobiotica; the fate of foreign compounds in biological systems

• Publication date

  2007-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/00498250701658296PMID 17968739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in Vivo

  2007influential reference
• The Prediction of Drug Metabolism, Tissue Distribution, and Bioavailability of 50 Structurally Diverse Compounds in Rat Using Mechanism-Based Absorption, Distribution, and Metabolism Prediction Tools

  2007influential reference
• Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

  2007cited by this paper
• Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies

  2007cited by this paper
• The pivotal role of hepatocytes in drug discovery.

  2007influential reference
• Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition.

  2007cited by this paper
• Comparison of Intrinsic Clearance in Liver Microsomes and Hepatocytes from Rats and Humans: Evaluation of Free Fraction and Uptake in Hepatocytes

  2006influential reference
• Drug-induced phospholipidosis: issues and future directions

  2006cited by this paper
• Uptake and Intracellular Binding of Lipophilic Amine Drugs by Isolated Rat Hepatocytes and Implications for Prediction of in Vivo Metabolic Clearance

  2006cited by this paper
• Molecular characterization and inhibition of amanitin uptake into human hepatocytes.

  2006cited by this paper
• THE ROLES OF TRANSPORTERS AND ENZYMES IN HEPATIC DRUG PROCESSING

  2005cited by this paper
• Apical/Basolateral Surface Expression of Drug Transporters and its Role in Vectorial Drug Transport

  2005influential reference
• Function and Regulation of Multidrug Resistance Proteins (MRPs) in the Renal Elimination of Organic Anions

  2005influential reference
• THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES

  2005cited by this paper
• Isolation and characterization of the Xenopus oocyte plasma membrane: a new method for studying activity of water and solute transporters.

  2005cited by this paper
• A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES

  2005influential reference
• Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity.

  2004cited by this paper
• Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches

  2004cited by this paper
• Development and validation of a method to determine the unbound paclitaxel fraction in human plasma.

  2004cited by this paper
• Ion-Trapping, Microsomal Binding, and Unbound Drug Distribution in the Hepatic Retention of Basic Drugs

  2004cited by this paper
• EFFECTS OF UREMIC TOXINS ON HEPATIC UPTAKE AND METABOLISM OF ERYTHROMYCIN

  2004cited by this paper
• The Complexities of Hepatic Drug Transport: Current Knowledge and Emerging Concepts

  2004cited by this paper
• PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones.

  2004cited by this paper
• An evaluation of the in vitro metabolism data for predicting the clearance and drug-drug interaction potential of CYP2C9 substrates.

  2004influential reference
• Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics.

  2004cited by this paper
• Rapid screening of small ligand affinity to human serum albumin by an optical biosensor.

  2003cited by this paper
• Inhibition of Transporter-Mediated Hepatic Uptake as a Mechanism for Drug-Drug Interaction between Cerivastatin and Cyclosporin A

  2003cited by this paper
• Impact of Drug Transporter Studies on Drug Discovery and Development

  2003influential reference
• In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.

  2002influential reference
• Free drug fraction vs free drug concentration: a matter of frequent confusion.

  2002cited by this paper
• Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method.

  2002influential reference
• Enterohepatic Circulation

  2002cited by this paper
• The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.

  2002cited by this paper
• Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface‐ and solution‐based biophysical methods

  2002cited by this paper
• Effects of serum albumin and liver cytosol on CYP2C9- and CYP3A4-mediated drug metabolism.

  2002cited by this paper
• Prediction of pharmacokinetic properties using experimental approaches during early drug discovery.

  2001influential reference
• Utility of metabolic stability screening: comparison of in vitro and in vivo clearance

  2001cited by this paper
• High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.

  2001influential reference
• P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes.

  2001cited by this paper
• An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant.

  2001influential reference
• Effect of zonal transport and metabolism on hepatic removal: enalapril hydrolysis in zonal, isolated rat hepatocytes in vitro and correlation with perfusion data.

  2000cited by this paper
• Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels.

  2000cited by this paper
• Lack of zonal uptake of estrone sulfate in enriched periportal and perivenous isolated rat hepatocytes.

  1999cited by this paper
• Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes.

  1999influential reference
• Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.

  1999cited by this paper
• Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats.

  1999cited by this paper
• Uptake and glutathione conjugation of ethacrynic acid and efflux of the glutathione adduct by periportal and perivenous rat hepatocytes.

  1999influential reference
• Bimolecular glutathione conjugation kinetics of ethacrynic acid in rat liver: in vitro and perfusion studies.

  1999cited by this paper
• Kinetic modeling of slow dissociation of bromosulphophthalein from albumin in perfused rat liver: toxicological implications.

  1999cited by this paper
• Prediction of Hepatic Metabolic Clearance Based on Interspecies Allometric Scaling Techniques and In Vitro-In Vivo Correlations

  1999influential reference
• Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport.

  1998influential reference
• Effect of albumin on the estimation, in vitro, of phenytoin Vmax and Km values: implications for clinical correlation.

  1997cited by this paper
• Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.

  1997cited by this paper
• Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes.

  1996influential reference
• Recent Advances in Carrier-mediated Hepatic Uptake and Biliary Excretion of Xenobiotics

  1996influential reference
• Uptake Is the Rate-limiting Step in the Overall Hepatic Elimination of Pravastatin at Steady-state in Rats

  1996influential reference
• Measurement and Analysis of Unbound Drug Concentrations

  1996cited by this paper
• PREDICTION OF IN VIVO DRUG DISPOSITION FROM IN VITRO DATA BASED ON PHYSIOLOGICAL PHARMACOKINETICS

  1996cited by this paper
• Administration of Escherichia coli endotoxin to rat increases liver mass and hepatocyte volume in vivo.

  1996cited by this paper
• Uptake of sulfate conjugates by isolated rat hepatocytes.

  1996influential reference
• The sinusoidal efflux of dibromosulfophthalein from rat liver is stimulated by albumin, ligandin and fatty acid binding protein but not by other dibromosulfophthalein binding proteins.

  1994cited by this paper
• Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver.

  1993influential reference
• Sequestration of organic cations by acidified hepatic endocytic vesicles and implications for biliary excretion.

  1992cited by this paper
• Uptake of organic anions by isolated rat hepatocytes. A classification in terms of ATP-dependency.

  1992influential reference
• Influence of albumin on the net sinusoidal efflux of the organic anion dibromosulfophthalein from rat liver

  1992cited by this paper
• On the design and interpretation of experiments to elucidate albumin-dependent hepatic uptake.

  1992cited by this paper
• Decreased ATP cost of isometric contractions in ATP-depleted rat fast-twitch muscle.

  1991cited by this paper
• Hepatic uptake of protein-bound ligands: extended sinusoidal perfusion model.

  1991cited by this paper
• Albumin enhances unidirectional fluxes of fatty acid across a lipid-water interface: theory and experiments.

  1989cited by this paper
• Conformational change in plasma albumin due to interaction with isolated rat hepatocyte.

  1988cited by this paper
• The series-compartment model for hepatic elimination.

  1987cited by this paper
• Dissociation from albumin: a potentially rate-limiting step in the clearance of substances by the liver.

  1985cited by this paper
• Albumin helps mediate removal of taurocholate by rat liver.

  1981cited by this paper
• Estimating the Dimension of a Model

  1978cited by this paper
• Posterior probabilities for choosing a regression model

  1978cited by this paper
• Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.

  1977cited by this paper

• Evolution of human pharmacokinetics prediction methods: from allometry to artificial intelligence

  2026cites this paper
• Concentration-dependent blood binding: assessing implications through physiologically based Pharmacokinetic modeling of tacrolimus as a case example

  2025cites this paper
• Carvedilol-loaded propolis nanoparticles embedded in gel-casted film and 3D electrospun nanofiber film – an in vivo study to enhance the bioavailability via the intranasal route

  2025cites this paper
• Insights into pharmacokinetic properties for exposure chemicals: predictive modelling of human plasma fraction unbound (fu) and hepatocyte intrinsic clearance (Clint) data using machine learning

  2024cites this paper
• Understanding plasma protein binding of drugs: considering complexity and binding dynamics.

  2024cites this paper
• Application of mechanistic multiparameter optimization and large scale in vitro to in vivo pharmacokinetics correlations to small molecule therapeutic projects

  2024cites this paper
• Lipophilic Group-Modified Manganese(II)-Based Contrast Agents for Vascular and Hepatobiliary Magnetic Resonance Imaging.

  2024cites this paper
• Using the Dynamic Well-Stirred Model to Extrapolate Hepatic Clearance of Organic Anion-Transporting Polypeptide Transporter Substrates without Assuming Albumin-Mediated Hepatic Drug Uptake

  2024cites this paper
• Trends of in vitro pharmacological potency and in vivo pharmacokinetics parameters of modern drugs: Can the therapeutic/subtherapeutic dose be estimated from in vitro K i and pharmacokinetic parameters?

  2024cites this paper
• Assumptions Underlying Hepatic Clearance Models: Recognizing the Influence of Saturable Protein Binding on Driving Force Concentration and Discrimination Between Models of Hepatic Clearance

  2023cites this paper
• Plasma protein-mediated uptake and contradictions to the free drug hypothesis: a critical review

  2023influential citation
• ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application

  2023cites this paper
• Evidence of the Need for Modified Well-stirred Model in In Vitro to In Vivo Extrapolation.

  2022cites this paper
• Altered Bioavailability and Pharmacokinetics in Crohn’s Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs

  2022cites this paper
• 64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window

  2022cites this paper
• Pharmacokinetics and in vivo evaluation of nanoparticles

  2022cites this paper
• Pesticides and vegetables: ecological and metabolic fate with their field and food significance

  2021cites this paper
• Hepatic transporter‐mediated pharmacokinetic drug–drug interactions: Recent studies and regulatory recommendations

  2021cites this paper
• Physiologically Based Models: Techniques and Applications to Drug Delivery

  2021cites this paper
• Assessment of the Kochak-Benet Equation for Hepatic Clearance for the Parallel-Tube Model: Relevance of Classic Clearance Concepts in PK and PBPK

  2021cites this paper
• Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design

  2020cites this paper
• A novel strategy for prediction of human plasma protein binding using machine learning techniques

  2020cites this paper
• Comparative Assessment Of Extrapolation Methods Based On The Conventional Free Drug Hypothesis And Plasma Protein-Mediated Hepatic Uptake Theory For The Hepatic Clearance Predictions Of Two Drugs Extensively Bound To Both The Albumin And Alpha-1-Acid Glycoprotein.

  2020cites this paper
• Pharmacokinetic and Pharmacodynamic Considerations

  2020cites this paper
• Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A1 adenosine receptor.

  2019cites this paper
• Relevance of In Vitro Metabolism Models to PET Radiotracer Development: Prediction of In Vivo Clearance in Rats from Microsomal Stability Data

  2019cites this paper
• Mechanistic modelling of in vitro transporter processes to improve drug-drug interaction predictions

  2019influential citation
• Synthesis and Evaluation of Bicyclic Hydroxypyridones as Inhibitors of Catechol O-Methyltransferase

  2019cites this paper
• A mechanistic modelling approach for the determination of the mechanisms of inhibition by cyclosporine on the uptake and metabolism of atorvastatin in rat hepatocytes using a high throughput uptake method

  2019influential citation
• Improvements for the in Vitro to in Vivo Extrapolation of Hepatic Clearance

  2019cites this paper
• The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs

  2019cites this paper
• Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties

  2019cites this paper
• Personalized medicine: going to the dogs?

  2019cites this paper
• Effect of Plasma Protein Binding on the Anti-Hepatitis B Virus Activity and Pharmacokinetic Properties of NVR 3-778

  2018cites this paper
• The impact of desorption kinetics from albumin on hepatic extraction efficiency and hepatic clearance: a model study

  2018cites this paper
• In vivo hepatic clearance of lipophilic drugs predicted by in vitro uptake data into cryopreserved hepatocytes suspended in sera of rats, guinea pigs, monkeys and humans

  2018cites this paper
• Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance.

  2018cites this paper
• In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models

  2018cites this paper
• An examination of protein binding and protein‐facilitated uptake relating to in vitro‐in vivo extrapolation

  2018cites this paper
• A toxicokinetic model for fish including multiphase sorption features

  2017cites this paper
• Relevance of in vitro metabolism models for PET radiotracer development

  2017cites this paper
• From Genotype to Phenotype: Cytochrome P450 2D6-Mediated Drug Clearance in Humans.

  2017cites this paper
• A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein‐bound drugs and the impact of errors in plasma protein binding

  2016cites this paper
• The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.

  2016cites this paper
• An introduction to physiologically‐based pharmacokinetic models

  2016cites this paper
• Development of in silico models for the prediction of toxicity incorporating ADME information

  2015cites this paper
• Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients

  2015cites this paper
• Characterization of plasma protein binding dissociation with online SPE-HPLC

  2015cites this paper
• SYSTEM-DEPENDENT METABOLISM OF DRUGS BY CYTOCHROME P450: THE MECHANISTIC BASIS FOR WHY HUMAN LIVER MICROSOMES ARE SUPERIOR TO HUMAN HEPATOCYTES AT METABOLIZING MIDAZOLAM BUT INFERIOR AT METABOLIZING DESLORATADINE

  2015influential citation
• Characterization of the comparative drug binding to intra- (liver fatty acid binding protein) and extra- (human serum albumin) cellular proteins

  2015cites this paper
• Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.

  2015cites this paper
• Modélisation de la toxicocinétique des isomères cis et trans de la perméthrine et de ses métabolites chez le rat et de leur métabolisme sur hépatocytes humains

  2014cites this paper
• Rationalizing underprediction of drug clearance from enzyme and transporter kinetic data: from in vitro tools to mechanistic modeling.

  2014cites this paper
• Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism

  2014cites this paper
• Maturation of cytochrome P450 3A mediated drug metabolism: Towards individualized dosing in children

  2013cites this paper
• On the maintenance of hepatocyte intracellular pH 7.0 in the in-vitro metabolic stability assay

  2013cites this paper
• A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine

  2013cites this paper
• Deriving an explicit hepatic clearance equation accounting for plasma protein binding and hepatocellular uptake.

  2013cites this paper
• Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME

  2013cites this paper
• Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic Model

  2012cites this paper
• Pharmacokinetics of Anticancer Materia Medica in Humans

  2012cites this paper
• Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs.

  2012cites this paper
• Assessment of biliary clearance in early drug discovery using sandwich-cultured hepatocyte model.

  2012cites this paper
• Determination of hepatic clearance with the account of drug-protein binding kinetics.

  2012cites this paper
• Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes

  2012cites this paper
• Probe ADME and Test Hypotheses: a PATH beyond clearance in vitro–in vivo correlations in early drug discovery

  2012cites this paper
• In Silico Models of Drug Metabolism and Drug Interactions

  2012cites this paper
• Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design.

  2012cites this paper
• Characterization of Rhodamine-123 as a Tracer Dye for Use In In vitro Drug Transport Assays

  2012cites this paper
• Clearance-dependent underprediction of in vivo intrinsic clearance from human hepatocytes: comparison with permeabilities from artificial membrane (PAMPA) assay, in silico and caco-2 assay, for 65 drugs.

  2012cites this paper
• Pharmacology of Pediatric Anesthesia

  2011cites this paper
• Compartmental modelling of the pharmacokinetics of a breast cancer resistance protein

  2011cites this paper
• The influence of hepatic transport on the distribution volumes and mean residence time of drug in the body and the accuracy of estimating these parameters by the traditional pharmacokinetic calculations.

  2011cites this paper
• A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytes

  2011influential citation
• Enabling Clearance Predictions to Emerge from In Silico Actions of Quasi-Autonomous Hepatocyte Components

  2011influential citation
• Dynamische Modellierung und Simulation des Arzneimittelmetabolismus in humanen Leberzellen: Identifizierbarkeit, Robustheit und inter-individuelle Variabilität

  2011influential citation
• Structure of albumin and transport of drugs

  2011cites this paper
• Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance

  2011cites this paper
• The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation.

  2011cites this paper
• In silico modelling of transporter-mediated xenobiotic flux through cells

  2010cites this paper
• Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis.

  2010cites this paper
• Prediction of Human Metabolic Clearance from In Vitro Systems: Retrospective Analysis and Prospective View

  2010cites this paper
• Plasma protein binding in drug discovery and development.

  2010cites this paper
• Challenges in the prediction and modeling of oral absorption and bioavailability.

  2010cites this paper
• Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development

  2009cites this paper
• Transporters – The View from Industry

  2009cites this paper
• Presentation of a modified dispersion model (MDM) for hepatic drug extraction and a new methodology for the prediction of the rate-limiting step in hepatic metabolic clearance

  2009influential citation
• Presentation of a modified dispersion model (MDM) for hepatic drug extraction and a new methodology for the prediction of the rate-limiting step in hepatic metabolic clearance.

  2009cites this paper
• A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates.

  2009cites this paper
• The use of drug metabolism for prediction of intestinal permeability (dagger).

  2009cites this paper
• Optimization of an isolated perfused rainbow trout liver model: Clearance studies with 7-ethoxycoumarin.

  2009cites this paper
• Methodological uncertainty in quantitative prediction of human hepatic clearance from in vitro experimental systems.

  2009cites this paper
• Interplay of drug metabolism and transport: a real phenomenon or an artifact of the site of measurement?

  2009cites this paper
• A PBPK model for midazolam in four avian species.

  2009cites this paper
• Design, Data Analysis, and Simulation of in Vitro Drug Transport Kinetic Experiments Using a Mechanistic in Vitro Model

  2008influential citation
• Plasma/serum protein binding determinations.

  2008cites this paper
• Enzyme-based assay for quantification of chlorpyrifos oxon in human plasma.

  2008cites this paper
• Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.

  2008cites this paper